Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SCOPOLAMINE Cause Intervertebral disc degeneration? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Intervertebral disc degeneration have been filed in association with SCOPOLAMINE (Scopolamine). This represents 0.2% of all adverse event reports for SCOPOLAMINE.

5
Reports of Intervertebral disc degeneration with SCOPOLAMINE
0.2%
of all SCOPOLAMINE reports
1
Deaths
1
Hospitalizations

How Dangerous Is Intervertebral disc degeneration From SCOPOLAMINE?

Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.

Is Intervertebral disc degeneration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SCOPOLAMINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does SCOPOLAMINE Cause?

Off label use (418) Nausea (313) Dizziness (293) Product adhesion issue (254) Drug ineffective (231) Vision blurred (212) Vomiting (201) Product quality issue (189) Mydriasis (180) Product use in unapproved indication (163)

What Other Drugs Cause Intervertebral disc degeneration?

ADALIMUMAB (873) ALENDRONATE (339) ETANERCEPT (311) METHOTREXATE (308) EMTRICITABINE\TENOFOVIR DISOPROXIL (210) PREGABALIN (204) PREDNISONE (202) RITUXIMAB (200) OXYCODONE (184) SODIUM OXYBATE (178)

Which SCOPOLAMINE Alternatives Have Lower Intervertebral disc degeneration Risk?

SCOPOLAMINE vs SCOPOLAMINE HYDROBROMIDE SCOPOLAMINE vs SEBELIPASE ALFA SCOPOLAMINE vs SECNIDAZOLE SCOPOLAMINE vs SECUKINUMAB SCOPOLAMINE vs SELADELPAR LYSINE

Related Pages

SCOPOLAMINE Full Profile All Intervertebral disc degeneration Reports All Drugs Causing Intervertebral disc degeneration SCOPOLAMINE Demographics